Bavarian Reperfusion Alternatives Evaluation - BRAVE

Description:

The goal of the trial was to evaluate abciximab therapy alone versus reteplase plus abciximab administered during the time from diagnosis to angiography among patients with ST elevation myocardial infarction (MI).